Immediate Impact
54 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of Eduardo Cervera being referenced
Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial
2010
Serum Albumin as a Significant Prognostic Factor for Patients with Gastric Carcinoma
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Eduardo Cervera | 28 | 10 | 182 | 232 | 109 | 11 | 479 | |
| Chang-Hsien Lu | 25 | 95 | 171 | 158 | 105 | 15 | 552 | |
| A Grant | 44 | 5 | 169 | 147 | 76 | 16 | 527 | |
| Iñaki Comino‐Méndez | 18 | 13 | 153 | 212 | 177 | 16 | 483 | |
| David H. Hwang | 10 | 7 | 125 | 170 | 95 | 21 | 468 | |
| T. Holbrook | 52 | 31 | 135 | 183 | 107 | 13 | 547 | |
| Kathryn Date | 45 | 15 | 216 | 235 | 131 | 9 | 544 | |
| Mohammed Rashid | 21 | 12 | 233 | 169 | 48 | 15 | 514 | |
| Yvonne Teng | 19 | 7 | 142 | 177 | 76 | 11 | 476 | |
| Haiqing Ma | 26 | 5 | 136 | 182 | 146 | 13 | 496 | |
| Megan Braunlin | 46 | 10 | 99 | 112 | 73 | 16 | 438 |
All Works
Loading papers...